Sun Pharmaceutical Industries Limited · NSE: SUNPHARMA · BSE: 524715

Sun Pharmaceutical Industries

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 31 Jul 2026.

Q1 FY27 · Consolidated

Revenue
15,299.88₹ Cr
+10.5% vs year ago
Net profit
2,901.23₹ Cr
+26.5% vs year ago
EPS, basic
12.10₹
+27.4% vs year ago
Net margin
19.0%
+2.4 pts vs year ago
Revenue₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹12,192.41 CrQ3 FY24: ₹12,380.70 CrQ4 FY24: ₹11,982.90 CrQ1 FY25: ₹12,652.75 CrQ2 FY25: ₹13,291.39 CrQ3 FY25: ₹13,675.46 CrQ4 FY25: ₹12,958.84 CrQ1 FY26: ₹13,851.40 CrQ2 FY26: ₹14,478.31 CrQ3 FY26: ₹15,520.54 CrQ4 FY26: ₹14,611.79 CrQ1 FY27: ₹15,299.88 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · consolidated · last 12 quarters
Q2 FY24: ₹2,385.10 CrQ3 FY24: ₹2,560.54 CrQ4 FY24: ₹2,658.74 CrQ1 FY25: ₹2,860.51 CrQ2 FY25: ₹3,037.33 CrQ3 FY25: ₹2,912.98 CrQ4 FY25: ₹2,153.93 CrQ1 FY26: ₹2,292.87 CrQ2 FY26: ₹3,124.95 CrQ3 FY26: ₹3,381.17 CrQ4 FY26: ₹2,709.66 CrQ1 FY27: ₹2,901.23 CrQ3 ’24Q1 ’25Q3 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Consolidated · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 202615,299.88+10.5%2,901.23+26.5%12.1031 Jul 2026
Q4 FY26Jan–Mar 202614,611.79+12.8%2,709.66+25.8%11.3022 May 2026
Q3 FY26Oct–Dec 202515,520.54+13.5%3,381.17+16.1%14.0031 Jan 2026
Q2 FY26Jul–Sep 202514,478.31+8.9%3,124.95+2.9%13.0005 Nov 2025
Q1 FY26Apr–Jun 202513,851.40+9.5%2,292.87−19.8%9.5031 Jul 2025
Q4 FY25Jan–Mar 202512,958.84+8.1%2,153.93−19.0%9.0022 May 2025
Q3 FY25Oct–Dec 202413,675.46+10.5%2,912.98+13.8%12.1031 Jan 2025
Q2 FY25Jul–Sep 202413,291.39+9.0%3,037.33+27.3%12.7028 Oct 2024
Q1 FY25Apr–Jun 202412,652.75+6.0%2,860.51+42.6%11.8002 Aug 2024
Q4 FY24Jan–Mar 202411,982.90+9.6%2,658.74+34.1%11.1023 May 2024
Q3 FY24Oct–Dec 202312,380.70+10.1%2,560.54+17.4%10.5001 Feb 2024
Q2 FY24Jul–Sep 202312,192.41+11.3%2,385.10+5.7%9.9002 Nov 2023
Q1 FY24Apr–Jun 202311,940.84+11.0%2,005.65−4.2%8.4003 Aug 2023
Q4 FY23Jan–Mar 202310,930.67+15.7%1,982.90Turned profit8.3026 May 2023
Q3 FY23Oct–Dec 202211,240.97+14.0%2,180.75+2.6%9.0031 Jan 2023
Q2 FY23Jul–Sep 202210,952.28+13.8%2,255.90+8.1%9.4002 Nov 2022
Q1 FY23Apr–Jun 202210,761.76+10.7%2,093.39+49.1%8.6030 Jul 2022
Q4 FY22Jan–Mar 20229,446.76+10.8%(2,227.38)Turned loss(9.50)31 May 2022
Q3 FY22Oct–Dec 20219,863.06+11.6%2,126.28+11.1%8.6031 Jan 2022
Q2 FY22Jul–Sep 20219,625.93+12.5%2,086.34+7.4%8.5002 Nov 2021
Q1 FY22Apr–Jun 20219,718.74+28.1%1,404.04Turned profit6.0031 Jul 2021
Q4 FY21Jan–Mar 20218,522.98+4.1%842.41+71.0%3.7028 May 2021
Q3 FY21Oct–Dec 20208,836.78+8.4%1,913.41+87.7%7.7230 Jan 2021
Q2 FY21Jul–Sep 20208,553.13+5.3%1,942.76+67.0%7.5604 Nov 2020
Q1 FY21Apr–Jun 20207,585.25−9.4%(2,426.23)Turned loss(6.90)01 Aug 2020
Q4 FY20Jan–Mar 20208,184.94+14.3%492.76−31.6%1.6728 May 2020
Q3 FY20Oct–Dec 20198,154.85+5.4%1,019.38−30.2%3.8107 Feb 2020
Q2 FY20Jul–Sep 20198,123.35+17.1%1,163.17Turned profit4.4308 Nov 2019
Q1 FY20Apr–Jun 20198,374.36+15.9%1,496.65+34.7%5.7813 Aug 2019
Q4 FY19Jan–Mar 20197,163.92—720.61—2.6529 May 2019
Q3 FY19Oct–Dec 20187,740.19—1,461.03—5.1813 Feb 2019
Q2 FY19Jul–Sep 20186,937.63—(108.84)—(0.91)14 Nov 2018
Q1 FY19Apr–Jun 20187,224.17—1,111.06—4.0914 Aug 2018
Standalone results
Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 20265,741.13+2.5%1,115.14+48.0%4.6031 Jul 2026
Q4 FY26Jan–Mar 20264,923.88−31.5%608.70−69.6%2.5022 May 2026
Q3 FY26Oct–Dec 20255,687.77−8.1%705.44−40.3%2.9031 Jan 2026
Q2 FY26Jul–Sep 20254,548.11−11.3%564.22−34.6%2.4005 Nov 2025
Q1 FY26Apr–Jun 20255,601.96+24.5%753.53+216.8%3.1031 Jul 2025
Q4 FY25Jan–Mar 20257,185.74+27.4%2,000.46+130.6%8.3022 May 2025
Q3 FY25Oct–Dec 20246,191.81+22.0%1,181.05+63.7%4.9031 Jan 2025
Q2 FY25Jul–Sep 20245,127.71+0.6%863.29−2.9%3.6028 Oct 2024
Q1 FY25Apr–Jun 20244,498.07+0.7%237.82−37.5%1.0002 Aug 2024
Q4 FY24Jan–Mar 20245,639.14−5.2%867.60Turned profit3.6023 May 2024
Q3 FY24Oct–Dec 20235,073.75+9.2%721.31+48.2%3.0001 Feb 2024
Q2 FY24Jul–Sep 20235,096.21−3.6%888.63−26.7%3.7002 Nov 2023
Q1 FY24Apr–Jun 20234,466.07−9.5%380.64−62.4%1.6003 Aug 2023
Q4 FY23Jan–Mar 20235,948.22+48.5%(1,020.82)Loss narrowed(4.30)26 May 2023
Q3 FY23Oct–Dec 20224,645.75+23.2%486.73−5.6%2.0031 Jan 2023
Q2 FY23Jul–Sep 20225,285.29+27.6%1,213.01+49.9%5.1002 Nov 2022
Q1 FY23Apr–Jun 20224,932.88+48.3%1,011.80+141.3%4.2030 Jul 2022
Q4 FY22Jan–Mar 20224,006.88+26.8%(1,286.21)Turned loss(5.40)31 May 2022
Q3 FY22Oct–Dec 20213,770.66+11.3%515.43−7.2%2.1031 Jan 2022
Q2 FY22Jul–Sep 20214,143.15+25.8%809.07+11.6%3.4002 Nov 2021
Q1 FY22Apr–Jun 20213,325.95+12.2%419.30−21.2%1.7531 Jul 2021
Q4 FY21Jan–Mar 20213,159.64+11.4%327.39−71.7%1.3628 May 2021
Q3 FY21Oct–Dec 20203,388.02+12.4%555.55+18.5%2.3230 Jan 2021
Q2 FY21Jul–Sep 20203,292.51−2.4%724.81−11.9%3.0204 Nov 2020
Q1 FY21Apr–Jun 20202,963.04−10.5%531.95−30.3%2.2201 Aug 2020
Q4 FY20Jan–Mar 20202,836.08+11.1%1,155.85+8.2%4.8228 May 2020
Q3 FY20Oct–Dec 20193,013.55+33.3%468.76Turned profit1.9507 Feb 2020
Q2 FY20Jul–Sep 20193,373.29+46.7%823.16Turned profit3.4308 Nov 2019
Q1 FY20Apr–Jun 20193,309.01+26.9%763.37+194.3%3.1813 Aug 2019
Q4 FY19Jan–Mar 20192,552.13—1,068.06—4.4529 May 2019
Q3 FY19Oct–Dec 20182,261.26—(38.68)—(0.16)13 Feb 2019
Q2 FY19Jul–Sep 20182,299.25—(906.42)—(3.78)14 Nov 2018
Q1 FY19Apr–Jun 20182,607.52—259.39—1.0814 Aug 2018

66 filings on record for this company.